Fu P - Search Results

1

Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients.

Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Fu P, Yamoah K, Khani F, Robinson BD, Rebbeck TR, Feldman M, Lal P, Madabhushi A. Bhargava HK, et al. Clin Cancer Res. 2020 Apr 15;26(8):1915-1923. doi: 10.1158/1078-0432.CCR-19-2659. Epub 2020 Mar 5. Clin Cancer Res. 2020. PMID: 32139401 Free PMC article.

2

Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma.

Gupta S, Hussain T, MacLennan GT, Fu P, Patel J, Mukhtar H. Gupta S, et al. J Clin Oncol. 2003 Jan 1;21(1):106-12. doi: 10.1200/JCO.2003.03.024. J Clin Oncol. 2003. PMID: 12506178

3

Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.

Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar H. Gupta S, et al. Cancer Res. 2004 May 1;64(9):3334-43. doi: 10.1158/0008-5472.can-03-2422. Cancer Res. 2004. PMID: 15126378

4

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.

Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, Resnick MI, Gupta S. Shukla S, et al. Neoplasia. 2004 Jul-Aug;6(4):390-400. doi: 10.1593/neo.04112. Neoplasia. 2004. PMID: 15256061 Free PMC article.

5

Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.

Shukla S, Mishra A, Fu P, MacLennan GT, Resnick MI, Gupta S. Shukla S, et al. FASEB J. 2005 Dec;19(14):2042-4. doi: 10.1096/fj.05-3740fje. Epub 2005 Oct 17. FASEB J. 2005. PMID: 16230333

6

The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study.

MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI, Gupta S. MacLennan GT, et al. J Urol. 2006 Sep;176(3):1012-6. doi: 10.1016/j.juro.2006.04.033. J Urol. 2006. PMID: 16890681

7

Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.

Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S. Shukla S, et al. Int J Cancer. 2007 Oct 1;121(7):1424-32. doi: 10.1002/ijc.22862. Int J Cancer. 2007. PMID: 17551921

8

Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice.

Shukla S, MacLennan GT, Flask CA, Fu P, Mishra A, Resnick MI, Gupta S. Shukla S, et al. Cancer Res. 2007 Jul 15;67(14):6925-35. doi: 10.1158/0008-5472.CAN-07-0717. Cancer Res. 2007. PMID: 17638904

9

Deregulation of FOXO3A during prostate cancer progression.

Shukla S, Shukla M, Maclennan GT, Fu P, Gupta S. Shukla S, et al. Int J Oncol. 2009 Jun;34(6):1613-20. doi: 10.3892/ijo_00000291. Int J Oncol. 2009. PMID: 19424579 Free PMC article.

10

Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.

Leidner RS, Fu P, Clifford B, Hamdan A, Jin C, Eisenberg R, Boggon TJ, Skokan M, Franklin WA, Cappuzzo F, Hirsch FR, Varella-Garcia M, Halmos B. Leidner RS, et al. J Clin Oncol. 2009 Nov 20;27(33):5620-6. doi: 10.1200/JCO.2009.23.1431. Epub 2009 Sep 28. J Clin Oncol. 2009. PMID: 19786660 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,694 results

Search Page

Filters